Biosystems, a Seattle-based technology company offering the world's
software and sensor suite for the detection and management of
traumatic brain injury, today announced the appointment of Major General
Stephen Layfield (U.S. Army, Ret.) as President of the company's
Government and Industrial Division.
X2 Biosystems' CEO Howard Green said Major General Layfield (Ret.) will
play a key role in advancing the company's growth and profitability
within the Government and Industrial Division. “Major General Layfield
is a proven military leader and a highly accomplished strategic planner.
His depth of knowledge and experience will be a true asset in driving
adoption of X2 Biosystems' technology within the military and industrial
Major General Layfield (Ret.) brings more than 30 years of senior
leadership, training, and command experience to his position. In
addition to his multiple operational deployments, Major General Layfield
(Ret.) has managed the training and development of diverse American and
multi-national organizations of up to 42,000 personnel. He oversaw
development of and investment in breakthrough training systems to
improve the performance of Joint Forces for the Department of Defense
and also served as Department of Defense Director for its most senior
leader development and educational program. The retired Major General
has applied his strategic leadership and planning expertise to help lead
the planning of several large scale military operations in the Middle
East. His exceptional service in deployments all over the world
including Bosnia, Former Yugoslav Republic of Macedonia, Afghanistan and
Operation Enduring Freedom has been recognized with numerous military
awards including the Bronze Star.
Commenting on his appointment, Major General Layfield (Ret.) said, “X2
Biosystems offers superior concussion management technology for members
of the military and industrial sector. I am particularly aware of the
importance this technology holds for our service men and women. It’s
essential to provide our armed forces with the most advanced health and
safety tools possible. I couldn't be more pleased to be part of a team
that is committed to furthering this mission.”
Unlike other existing concussion assessment tools, X2 Biosystems'
state-of-the-art technology provides comprehensive, real-time,
end-to-end management of concussive and traumatic brain injury events
promoting standards of care and coordinating return to activity. The
rigorous system is being tested for use by the military and is being
used by professional, amateur, collegiate and youth sports organizations
because its advanced capabilities and distinctive features deliver a
superior technology that is both sensitive and robust with the
portability, simplicity, and ease-of-use that is effective in even the
most demanding conditions.
About X2 Biosystems
X2 Biosystems is a privately held Seattle-based science and technology
company that has developed the world’s first systems for comprehensive,
end-to-end, real-time management of concussion and other brain injuries.
Learn how X2 Biosystems' state-of-the-art technology is improving the
health and well-being of athletes, the military, and industrial
employees at www.x2biosystems.com
or email email@example.com.